The need for understandable and transparent pricing for medical services in the U.S. has increased in urgency with the continuing rise of out-of-pocket healthcare costs. Americans are delaying ...

FDA today announced the issuance of warning letters to two Chinese nonclinical testing laboratories who provide third-party testing and validation services to device manufacturers for use in premarket ...